Ethics approval and consent to participate
The trial was conducted in accordance with the Declaration of Helsinki and approved and supervised by the Fujian Provincial Hospital Ethics Committee (K2020-09–075). All patients provided written informed consent prior to participating in the study. The trial protocol was registered in the Chinese Clinical Trial Registry (ChiCTR2000040311).